Join
Live feed
·
INSIDERFilingvia Quantisnow
Opiant Pharmaceuticals Inc. logo

SEC Form 4: Ellison Mark Jason Heath sold $12,359 worth of shares (610 units at $20.26), decreasing direct ownership by 3% to 18,751 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
OPNT· Opiant Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPNT (Opiant Pharmaceuticals Inc.) and more on Quantisnow.